Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Medpace Holdings Inc (MEDP) vs VICI Properties Inc (VICI) Price & Performance

Medpace Holdings IncTrade
VICI Properties IncTrade

Price performance (Past 24H)

Key statistics

Medpace Holdings Inc vs VICI Properties Inc — how do they compare? Medpace Holdings Inc trades at $597.39 (market cap $16.90B), while VICI Properties Inc trades at $26.07 (market cap $28.61B). The key difference: VICI Properties Inc is the larger of the two by market cap, and VICI Properties Inc pays a 6.93% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals.

MEDPVICI
Market Cap
$16.90B$28.61B
Sector
TechnologyReal Estate
52-Week High
$620.59$33.78
52-Week Low
$393.42$25.94
Enterprise Value
$16.52B$46.16B
Dividend Yield
6.93%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Medpace Holdings Inc

MEDP trades at $596.98, down 0.9% on the day but near its 52-week highs. The stock shows strong technical momentum with bullish moving averages and recent golden cross formation. Fundamentally, the company delivered three consecutive quarterly earnings beats with Q2 2026 EPS of $4.25 beating expectations of $3.98. Revenue growth remains robust at 17.2% year-over-year in Q2 2026, supported by record net bookings and a $3.0 billion backlog.

MEDP presents a growth story with strong fundamentals but trades at premium valuations (P/E 35.58, P/S 6.27). The primary investment opportunity lies in continued execution on record bookings and backlog conversion. Key risks include the ongoing shareholder litigation investigation and potential valuation compression if growth moderates. Analyst consensus targets $599.57 with 21% buy ratings, suggesting limited near-term upside from current levels.

VICI Properties Inc

VICI Properties trades at $26.07, down slightly by 0.02% on the day. The stock shows a bearish technical signal with moving averages indicating selling pressure, while fundamentals remain solid with a P/E of 10.07 and strong profitability margins. Recent Q2 2026 earnings missed EPS estimates but revenue beat, and the company raised its full-year AFFO guidance. A dividend of $0.45 per share was recently declared, supporting income appeal.

The outlook is mixed; analyst consensus is strongly bullish with a $29.83 price target, but near-term volatility exists due to the Caesars buyout overhang. The 6.6% dividend yield and balance sheet strength provide downside cushion, though high debt and interest expenses pose risks. Upside depends on execution of growth initiatives and stable cash flows from its real estate portfolio.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Medpace Holdings Inc

Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.

Read more on MEDP

About VICI Properties Inc

VICI Properties is an S&P 500 experiential real estate investment trust (REIT) that owns one of the largest portfolios of market-leading gaming, hospitality, and entertainment destinations, including Caesars Palace and MGM Grand. It utilizes a long-term, triple-net lease model to provide stable, inflation-protected income, serving as the primary landlord for the 'experience economy' while diversifying into non-gaming sectors like wellness, youth sports, and luxury resorts.

Read more on VICI